Keeping Up with the Feds: From FDA to HRSA, Washington Backs Psychedelics By Watertime - July 13, 2026 6 Post Content RELATED ARTICLESMORE FROM AUTHOR Weekly Psychedelic Policy Briefing, September 21, 2026 Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
